BeAble Health, Jeevaniyam, and IIT Hyderabad have signed a collaborative agreement to enhance AI-based paediatric care through joint development of intelligent diagnostic and therapeutic tools. The partnership focuses on creating AI solutions for early detection of developmental disorders, neurodevelopmental conditions, and childhood diseases, combining clinical expertise with advanced machine learning to improve screening, intervention planning, and long-term monitoring for children in India.
Glimpse:
The collaboration brings together BeAble Health’s paediatric rehabilitation technology, Jeevaniyam’s clinical experience in child development and neurorehabilitation, and IIT Hyderabad’s AI research capabilities to build predictive models, automated screening tools, personalized therapy recommendations, and tele-rehabilitation platforms. The initiative targets high-prevalence conditions like autism spectrum disorder, cerebral palsy, developmental delays, and speech-language impairments, with initial pilots planned in Kerala and Telangana, aiming to scale affordable, evidence-based paediatric care across India.
Full news story BeAble Health, a healthtech startup specializing in paediatric rehabilitation devices, Jeevaniyam a leading child development and neurorehabilitation centre in Kerala and the Indian Institute of Technology (IIT) Hyderabad have signed a strategic collaboration agreement to jointly develop and deploy AI-powered solutions for paediatric care. The partnership, formalized on February 27, 2026, was announced during a joint press meet in Hyderabad and aims to address critical gaps in early diagnosis, intervention, and long-term management of childhood developmental and neurological conditions across India.
The collaboration leverages IIT Hyderabad’s expertise in artificial intelligence, machine learning, and data analytics alongside BeAble Health’s innovative therapy devices and Jeevaniyam’s extensive clinical experience treating thousands of children with autism spectrum disorder, cerebral palsy, global developmental delay, ADHD, speech-language disorders, and other neurodevelopmental conditions. Together, the partners will create AI tools for automated screening using video analysis of child behaviour, predictive models for developmental risk assessment based on early milestones and parental inputs, personalized therapy planning, and tele-rehabilitation platforms that allow remote monitoring and guided home interventions.
The initiative will begin with pilot projects in Kerala and Telangana, integrating AI-driven assessments into Jeevaniyam’s clinical workflows and BeAble Health’s device ecosystem to generate real-time insights for therapists and parents. The AI models will be trained on anonymized Indian paediatric datasets to ensure cultural and demographic relevance, with rigorous clinical validation to meet medical standards. The partnership also includes joint research publications, clinician training programs, and startup incubation support to nurture additional innovations in child health tech.
All three partners emphasized that the collaboration is driven by the urgent need to improve early intervention in India, where developmental disorders often go undetected until later ages due to limited access to specialists, long waiting lists, and high costs. By combining clinical knowledge with AI capabilities, the group aims to make screening faster, therapy more personalized, and outcomes more measurable ultimately reducing the lifelong impact of untreated conditions on children and families.
The MoU is initially set for a three-year term, with plans for expansion into additional states, integration with national programs like the Rashtriya Bal Swasthya Karyakram (RBSK), and potential commercialization of co-developed tools. The partnership has already received strong interest from paediatricians, child development experts, and public health officials who see it as a model for academia-industry-clinical convergence in addressing child health challenges.
“Children deserve the earliest possible support AI can help us detect and act on developmental risks long before they become lifelong challenges. This partnership brings together the best of clinical care, technology, and research to make that vision a reality for every child in India.”
By
HB Team
Related News
